IL202825A0 - A transition metal catalyzed synthesis of 2h-indazoles - Google Patents

A transition metal catalyzed synthesis of 2h-indazoles

Info

Publication number
IL202825A0
IL202825A0 IL202825A IL20282509A IL202825A0 IL 202825 A0 IL202825 A0 IL 202825A0 IL 202825 A IL202825 A IL 202825A IL 20282509 A IL20282509 A IL 20282509A IL 202825 A0 IL202825 A0 IL 202825A0
Authority
IL
Israel
Prior art keywords
indazoles
transition metal
metal catalyzed
catalyzed synthesis
phenylacetylenes
Prior art date
Application number
IL202825A
Other languages
English (en)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of IL202825A0 publication Critical patent/IL202825A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Catalysts (AREA)
IL202825A 2007-06-26 2009-12-17 A transition metal catalyzed synthesis of 2h-indazoles IL202825A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07290799 2007-06-26
PCT/EP2008/004637 WO2009000411A1 (en) 2007-06-26 2008-06-11 A transition metal catalyzed synthesis of 2h-indazoles

Publications (1)

Publication Number Publication Date
IL202825A0 true IL202825A0 (en) 2010-06-30

Family

ID=38577414

Family Applications (1)

Application Number Title Priority Date Filing Date
IL202825A IL202825A0 (en) 2007-06-26 2009-12-17 A transition metal catalyzed synthesis of 2h-indazoles

Country Status (12)

Country Link
US (1) US8283476B2 (https=)
EP (1) EP2170833B1 (https=)
JP (1) JP5250029B2 (https=)
KR (1) KR20100024963A (https=)
CN (1) CN101687809A (https=)
AT (1) ATE511501T1 (https=)
AU (1) AU2008267442A1 (https=)
BR (1) BRPI0813870A2 (https=)
CA (1) CA2693024A1 (https=)
IL (1) IL202825A0 (https=)
MX (1) MX2009014203A (https=)
WO (1) WO2009000411A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2697203B1 (en) * 2011-04-13 2017-05-24 Merck Sharp & Dohme Corporation Mineralocorticoid receptor antagonists
ES2661585T3 (es) * 2012-10-31 2018-04-02 Raqualia Pharma Inc Derivados de pirazolopiridina como bloqueadores de TTX-S
CN103232462B (zh) * 2013-05-13 2016-03-02 湖北科技学院 香豆素-吡咯类化合物的合成方法
BR112017019326B1 (pt) * 2015-03-12 2022-04-26 Fmc Corporation Composto, composição e método para controlar uma praga invertebrada
KR101931234B1 (ko) 2016-02-12 2018-12-21 주식회사 엘지화학 신규한 리간드 화합물 및 전이금속 화합물
WO2017138783A1 (ko) * 2016-02-12 2017-08-17 주식회사 엘지화학 신규한 리간드 화합물 및 전이금속 화합물
KR102095007B1 (ko) * 2016-02-12 2020-03-30 주식회사 엘지화학 신규한 리간드 화합물 및 전이금속 화합물의 제조방법
KR102038977B1 (ko) * 2016-12-30 2019-11-01 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 신규한 시클로펜타[b]티오펜일 전이금속 화합물, 이를 포함하는 전이금속 촉매 조성물, 및 이를 이용한 에틸렌 단독중합체 또는 에틸렌과 α-올레핀의 공중합체의 제조방법
CA3100923A1 (en) 2018-06-04 2019-12-12 Exscientia Ltd Pyrazolopyrimidine compounds as adenosine receptor antagonists
CN110317204B (zh) * 2019-08-02 2022-02-08 安徽农业大学 吡唑并嘧啶酮类衍生物及其制备方法和应用
GB202017990D0 (en) * 2020-11-16 2020-12-30 Syngenta Crop Protection Ag Improvements in or relating to organic compounds
CN113698349B (zh) * 2021-09-02 2023-08-01 河南师范大学 一种2-(2-苯基-2h-吲唑-3-基)乙酸酯类化合物的水相光催化制备方法
CN114920699B (zh) * 2022-05-31 2024-03-19 甘肃皓天科技股份有限公司 一种制备6-氯-2-甲基-2h-吲唑-5-胺的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE229499T1 (de) * 1998-02-26 2002-12-15 Massachusetts Inst Technology Metallkatalysierte arylierungen und vinylierungen von hydrazinen, hydrazonen, hydroxylaminen und oximen

Also Published As

Publication number Publication date
EP2170833A1 (en) 2010-04-07
ATE511501T1 (de) 2011-06-15
EP2170833B1 (en) 2011-06-01
KR20100024963A (ko) 2010-03-08
CN101687809A (zh) 2010-03-31
CA2693024A1 (en) 2008-12-31
AU2008267442A1 (en) 2008-12-31
BRPI0813870A2 (pt) 2015-01-06
MX2009014203A (es) 2010-01-28
JP5250029B2 (ja) 2013-07-31
US8283476B2 (en) 2012-10-09
US20100234601A1 (en) 2010-09-16
WO2009000411A1 (en) 2008-12-31
JP2010531311A (ja) 2010-09-24

Similar Documents

Publication Publication Date Title
IL202825A0 (en) A transition metal catalyzed synthesis of 2h-indazoles
IL202823A0 (en) A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
IL201253A0 (en) A transition metal catalyzed synthesis of n - aminoindoles
MX2009013591A (es) Proceso para la preparacion de pirazoles.
TW200720271A (en) DNA-PK inhibitors
WO2007085895A3 (en) Fap inhibitors
MX2010009416A (es) Compuestos heterociclicos como inhibidores de cxcr2.
MX2010002243A (es) Derivados fungicidas de 2-alquiltio-2-quinoliniloxi-acetamida.
WO2008063781A3 (en) Chemical compounds as cannabinoid receptor ligands
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
UA102817C2 (ru) Способ синтеза агомелатина
UA95972C2 (ru) Аминопиридиновые производные с селективной ингибирующей активностью в отношении авроры а
PH12012501125A1 (en) 3, 4, 4a, 10b - tetrahydro -1h- thiopyrano -[4, 3-c] isoquinoline derivatives
UA102220C2 (ru) Способ синтеза агомелатина
WO2009054439A1 (ja) Pai-1産生抑制剤
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
MX2009006533A (es) Derivados de indolil-maleimida como inhibidores de cinasa.
SG151207A1 (en) New process for the synthesis of strontium ranelate and its hydrates
ZA200801875B (en) Isoquinolines as IGF-IR inhibitors
MY147502A (en) Substituted pyrazoles, compositions containing these, method of production and use
TW200640912A (en) Novel processes for the preparation of a 2H-chromene
WO2008019030A3 (en) Modified azole compounds as antiinfective agents
ZA200903052B (en) Removal of hydrogen cyanide from synthesis gas
MY154498A (en) Pyrazolone derivatives as pde4 inhibitors
TW200738621A (en) Chemical process